Pfizer CentreOne Header Pfizer CentreOne Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Suppliers of Candesartan Cilexetil intermediates listed on PharmaCompass.com

    Client Email Product

    Candesartan Cilexetil

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    62
    US DMFs Filed

    US DMFs Filed

    23
    CEP/COS Certifications

    CEP/COS Certifications

    23
    JDMFs Filed

    JDMFs Filed

    15
    Other Certificates

    Other Certificates

    15
    Other Suppliers

    Other Suppliers

    20
    API REF. PRICE (USD / KG)
    747

    API Market Place

    10
    INTERMEDIATES
    20
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    48
    Europe

    Europe

    542
    Canada

    Canada

    79
    Australia

    Australia

    1
    South Africa

    South Africa

    21
    Uploaded Dossiers

    Uploaded Dossiers

    45
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    365.00

    Annual Reports

    0

    FDF Market Place

    2
    EXCIPIENTS
    109
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    2

    News

    30
    REF STANDARD

    EDQM

    3

    USP

    6

    JP

    0

    Other Listed Suppliers

    7
    SERVICES

    0

    left grey arrow
    right gray arrow
    ListList of Suppliers
    Full View ScreenFull Screen View
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info

    Jiangsu Zhongbang Pharmaceutical Co...

    Contact Supplier
    • Audit Compliance
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    TritylCandesartan Cilexetil

    PDF Supplier PDF
    URL Supplier Web Content
    170791-09-0
    Candesartan Cilexetil
    Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has bee...
    Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has been founded since 2001 and occupied 100,000m2. Company has 80 million RMB registered capital and plan to have a total investment of 200 million RMB. Company has 168 employees at present, in which there are 34 employees with Bachelor’s Degree or above, 12 employees with Master’s Degree or above, each kind of professional talents have occupied over 60% of the total employees. Company has got China GMP certificate since 2006 and currently has one GMP plant for API and one GMP plant for solid finished products. There are two production lines in API GMP plants with annual capacity of 50 tons API. There are equipment for tablets, capsules and granules in solid finished products. Company has set up qualified documentation systems according to China GMP and Europe and USA C-GMP. Company has the plan to pass COS and FDA authentication both around 2014. Company also pays serious attention on public welfare and concerns on green energy conservation and environmental protection undertaking.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Smilax Laboratories Limited

    Contact Supplier
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Methyl 3-((2'-cyanobiphenyl-4-yl) methyl)-2-ethoxy-3H-b...

    PDF Supplier PDF
    URL Supplier Web Content
    139481-44-0
    Candesartan Cilexetil
    Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufactur...
    Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufacturing Active Pharmaceutical Ingredients, API Intermediates and NDDS/Pellets for the generics market across the world. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today.Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Smilax manufactures APIs and API Intermediates at its state-of-the-art manufacturing facilities located at Hyderabad, Telangana and Visakhapatnam, Andhra Pradesh, India. Supported by a highly qualified and competent technical team, and endowed with strengths in research and development, Smilax continues to expand its presence in the world of pharmaceuticals.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Smilax Laboratories Limited

    Contact Supplier
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Methyl 3-((2'-(2H-tetrazol-5- yl)biphenyl-4-yl)methyl)-...

    PDF Supplier PDF
    URL Supplier Web Content
    124750-51-2
    Candesartan Cilexetil
    Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufactur...
    Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufacturing Active Pharmaceutical Ingredients, API Intermediates and NDDS/Pellets for the generics market across the world. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today.Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Smilax manufactures APIs and API Intermediates at its state-of-the-art manufacturing facilities located at Hyderabad, Telangana and Visakhapatnam, Andhra Pradesh, India. Supported by a highly qualified and competent technical team, and endowed with strengths in research and development, Smilax continues to expand its presence in the world of pharmaceuticals.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Smilax Laboratories Limited

    Contact Supplier
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    3-((2'-(2H-Tetrazol-5-yl)biphenyl-4- yl)methyl)-2-ethox...

    PDF Supplier PDF
    URL Supplier Web Content
    139481-59-7
    Candesartan Cilexetil
    Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufactur...
    Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufacturing Active Pharmaceutical Ingredients, API Intermediates and NDDS/Pellets for the generics market across the world. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today.Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Smilax manufactures APIs and API Intermediates at its state-of-the-art manufacturing facilities located at Hyderabad, Telangana and Visakhapatnam, Andhra Pradesh, India. Supported by a highly qualified and competent technical team, and endowed with strengths in research and development, Smilax continues to expand its presence in the world of pharmaceuticals.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Zhejiang Huahai Pharmaceutical Co.,...

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Ethyl 2-ethoxy-1-[(2'-cyanobiphenyl-4-yl)-methyl]-1H- ...

    PDF Supplier PDF
    URL Supplier Web Content
    139481-41-7
    Candesartan Cilexetil
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was succe...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Zhejiang Huahai Pharmaceutical Co.,...

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]...

    PDF Supplier PDF
    URL Supplier Web Content
    139481-59-7
    Candesartan Cilexetil
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was succe...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Zhejiang Huahai Pharmaceutical Co.,...

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Methyl 2-ethoxy-1-[(2'-cyanobiphenyl-4-yl)-methyl]-1H-...

    PDF Supplier PDF
    URL Supplier Web Content
    139481-44-0
    Candesartan Cilexetil
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was succe...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Zhejiang Huahai Pharmaceutical Co.,...

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    2-Ethoxy-1-[[2'-(N-triphenylmethyltetrazol-5-yl)-biphen...

    PDF Supplier PDF
    URL Supplier Web Content
    139481-72-4
    Candesartan Cilexetil
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was succe...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Zhejiang Huahai Pharmaceutical Co.,...

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1-tr...

    PDF Supplier PDF
    URL Supplier Web Content
    170791-09-0
    Candesartan Cilexetil
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was succe...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Zhuhai Rundu Pharmaceutical Co.,Ltd

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Ethyl 2-[(tert-butoxycarbonyI)amino]-3-nitrobenzoate

      PDF Supplier PDF
      URL Supplier Web Content
      136285-65-9
      Candesartan Cilexetil
      Zhuhai Rundu Pharmaceutical Co., Ltd. is a modern scientific and technological pharmaceutical enterprise ...
      Zhuhai Rundu Pharmaceutical Co., Ltd. is a modern scientific